The DOI matches its Crossref record; 130 of the 130 references it cites were found in a registry or an index.
Wnt signalling in osteoporosis: mechanisms and novel therapeutic approaches
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wnt/β-Catenin Signaling in Development and Disease
Clevers, H. (2006) · Cell · doi:10.1016/j.cell.2006.10.018 · Cited by 5,568
Osteoporosis Prevention, Diagnosis, and Therapy
NIH Consensus Development Panel on Osteoporosis Prevention, D. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.6.785 · Cited by 5,529
Nakashima, K., Zhou, X., Kunkel, G., Zhang, Z., Deng, J. M., Behringer, R. R., & de Crombrugghe, B. (2002) · Cell · doi:10.1016/s0092-8674(01)00622-5 · Cited by 3,608
Functional interaction of β-catenin with the transcription factor LEF-1
Behrens, J., von Kries, J. P., Kühl, M., Bruhn, L., Wedlich, D., Grosschedl, R., & Birchmeier, W. (1996) · Nature · doi:10.1038/382638a0 · Cited by 2,912
Bonewald, L. F. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.320 · Cited by 2,287
LDL Receptor-Related Protein 5 (LRP5) Affects Bone Accrual and Eye Development
Gong, Y., Slee, R. B., Fukai, N., Rawadi, G., Roman-Roman, S., Reginato, A. M., Wang, H., Cundy, T., Glorieux, F. H., Lev, D., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00571-2 · Cited by 2,235
Bone Quality — The Material and Structural Basis of Bone Strength and Fragility
Seeman, E., & Delmas, P. D. (2006) · New England Journal of Medicine · doi:10.1056/nejmra053077 · Cited by 2,080
Control of β-Catenin Phosphorylation/Degradation by a Dual-Kinase Mechanism
Liu, C., Li, Y., Semenov, M., Han, C., Baeg, G.-H., Tan, Y., Zhang, Z., Lin, X., & He, X. (2002) · Cell · doi:10.1016/s0092-8674(02)00685-2 · Cited by 2,069
Evidence for osteocyte regulation of bone homeostasis through RANKL expression
Nakashima, T., Hayashi, M., Fukunaga, T., Kurata, K., Oh-hora, M., Feng, J. Q., Bonewald, L. F., Kodama, T., Wutz, A., Wagner, E. F., et al. (2011) · Nature Medicine · doi:10.1038/nm.2452 · Cited by 1,778
Day, T. F., Guo, X., Garrett-Beal, L., & Yang, Y. (2005) · Developmental Cell · doi:10.1016/j.devcel.2005.03.016 · Cited by 1,616
Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction
Glinka, A., Wu, W., Delius, H., Monaghan, A. P., Blumenstock, C., & Niehrs, C. (1998) · Nature · doi:10.1038/34848 · Cited by 1,608
High Bone Density Due to a Mutation in LDL-Receptor–Related Protein 5
Boyden, L. M., Mao, J., Belsky, J., Mitzner, L., Farhi, A., Mitnick, M. A., Wu, D., Insogna, K., & Lifton, R. P. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013444 · Cited by 1,591
Secreted antagonists of the Wnt signalling pathway
Kawano, Y., & Kypta, R. (2003) · Journal of Cell Science · doi:10.1242/jcs.00623 · Cited by 1,584
Canonical wnt signaling in differentiated osteoblasts controls osteoclast differentiation.
Glass, D. A., Bialek, P., Ahn, J. D., Starbuck, M., Patel, M. S., Clevers, H., Taketo, M. M., Long, F., McMahon, A. P., Lang, R. A., et al. (2005) · Developmental Cell · doi:10.1016/j.devcel.2005.02.017 · Cited by 1,558
Linking Colorectal Cancer to Wnt Signaling
Bienz, M., & Clevers, H. (2000) · Cell · doi:10.1016/s0092-8674(00)00122-7 · Cited by 1,515
Tian, E., Zhan, F., Walker, R., Rasmussen, E., Ma, Y., Barlogie, B., & Shaughnessy, J. D. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030847 · Cited by 1,503
Regulation of bone mass by Wnt signaling
Krishnan, V. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28551 · Cited by 1,407
Sclerostin Binds to LRP5/6 and Antagonizes Canonical Wnt Signaling
Li, X., Zhang, Y., Kang, H., Liu, W., Liu, P., Zhang, J., Harris, S. E., & Wu, D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413274200 · Cited by 1,366
Mechanical Stimulation of Bone in Vivo Reduces Osteocyte Expression of Sost/Sclerostin
Robling, A. G., Niziolek, P. J., Baldridge, L. A., Condon, K. W., Allen, M. R., Alam, I., Mantila, S. M., Gluhak-Heinrich, J., Bellido, T. M., Harris, S. E., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m705092200 · Cited by 1,350
Matrix-embedded cells control osteoclast formation
Xiong, J., Onal, M., Jilka, R. L., Weinstein, R. S., Manolagas, S. C., & O'Brien, C. A. (2011) · Nature Medicine · doi:10.1038/nm.2448 · Cited by 1,304
Little, R. D., Folz, C., Manning, S. P., Swain, P. M., Zhao, S.-C., Eustace, B., Lappe, M. M., Spitzer, L., Zweier, S., Braunschweiger, K., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/338450 · Cited by 1,282
van de Wetering, M., Cavallo, R., Dooijes, D., van Beest, M., van Es, J., Loureiro, J., Ypma, A., Hursh, D., Jones, T., Bejsovec, A., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)81925-x · Cited by 1,202
Canonical WNT Signaling Promotes Osteogenesis by Directly Stimulating Runx2 Gene Expression
Gaur, T., Lengner, C. J., Hovhannisyan, H., Bhat, R. A., Bodine, P. V. N., Komm, B. S., Javed, A., van Wijnen, A. J., Stein, J. L., Stein, G. S., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500608200 · Cited by 1,170
Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)
Balemans, W. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.5.537 · Cited by 1,147
Glucocorticoid-induced osteoporosis: pathophysiology and therapy
Canalis, E., Mazziotti, G., Giustina, A., & Bilezikian, J. P. (2007) · Osteoporosis International · doi:10.1007/s00198-007-0394-0 · Cited by 1,114
Self-citationOsteocyte control of bone formation via sclerostin, a novel BMP antagonist
Winkler, D. G. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg599 · Cited by 1,112
Kato, M., Patel, M. S., Levasseur, R., Lobov, I., Chang, B. H.-J., Glass, D. A., Hartmann, C., Li, L., Hwang, T.-H., Brayton, C. F., et al. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200201089 · Cited by 1,086
Kremen proteins are Dickkopf receptors that regulate Wnt/β-catenin signalling
Mao, B., Wu, W., Davidson, G., Marhold, J., Li, M., Mechler, B. M., Delius, H., Hoppe, D., Stannek, P., Walter, C., et al. (2002) · Nature · doi:10.1038/nature756 · Cited by 1,038
Brunkow, M. E., Gardner, J. C., Van Ness, J., Paeper, B. W., Kovacevich, B. R., Proll, S., Skonier, J. E., Zhao, L., Sabo, P. J., Fu, Y.-H., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/318811 · Cited by 1,011
Function and biological roles of the Dickkopf family of Wnt modulators
Niehrs, C. (2006) · Oncogene · doi:10.1038/sj.onc.1210054 · Cited by 995
A Wnt5a pathway underlies outgrowth of multiple structures in the vertebrate embryo
Yamaguchi, T. P., Bradley, A., McMahon, A. P., & Jones, S. (1999) · Development · doi:10.1242/dev.126.6.1211 · Cited by 970
Li, X., Ominsky, M. S., Niu, Q.-T., Sun, N., Daugherty, B., D'Agostin, D., Kurahara, C., Gao, Y., Cao, J., Gong, J., et al. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080216 · Cited by 936
van Bezooijen, R. L., Roelen, B. A. J., Visser, A., van der Wee-Pals, L., de Wilt, E., Karperien, M., Hamersma, H., Papapoulos, S. E., ten Dijke, P., & Löwik, C. W. G. M. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031454 · Cited by 892
Regulation of osteoblastogenesis and bone mass by Wnt10b
Bennett, C. N., Longo, K. A., Wright, W. S., Suva, L. J., Lane, T. F., Hankenson, K. D., & MacDougald, O. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408742102 · Cited by 881
Bone Morphogenetic Proteins, Their Antagonists, and the Skeleton
Canalis, E., Economides, A. N., & Gazzerro, E. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0023 · Cited by 863
Self-citationTargeted ablation of osteocytes induces osteoporosis with defective mechanotransduction.
Tatsumi, S., Ishii, K., Amizuka, N., Li, M., Kobayashi, T., Kohno, K., Ito, M., Takeshita, S., & Ikeda, K. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.001 · Cited by 848
The head inducer Cerberus is a multifunctional antagonist of Nodal, BMP and Wnt signals
Piccolo, S., Agius, E., Leyns, L., Bhattacharyya, S., Grunz, H., Bouwmeester, T., & Robertis, E. M. D. (1999) · Nature · doi:10.1038/17820 · Cited by 832
Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody
Padhi, D., Jang, G., Stouch, B., Fang, L., & Posvar, E. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.173 · Cited by 786
Li, X., Ominsky, M. S., Warmington, K. S., Morony, S., Gong, J., Cao, J., Gao, Y., Shalhoub, V., Tipton, B., Haldankar, R., et al. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.081206 · Cited by 784
Bouwmeester, T., Kim, S.-H., Sasai, Y., Lu, B., & Robertis, E. M. D. (1996) · Nature · doi:10.1038/382595a0 · Cited by 759
Interactions between Sox9 and β-catenin control chondrocyte differentiation
Akiyama, H., Lyons, J. P., Mori-Akiyama, Y., Yang, X., Zhang, R., Zhang, Z., Deng, J. M., Taketo, M. M., Nakamura, T., Behringer, R. R., et al. (2004) · Genes & Development · doi:10.1101/gad.1171104 · Cited by 754
A new secreted protein that binds to Wnt proteins and inhibits their activites
Hsieh, J.-C., Kodjabachian, L., Rebbert, M. L., Rattner, A., Smallwood, P. M., Samos, C. H., Nusse, R., Dawid, I. B., & Nathans, J. (1999) · Nature · doi:10.1038/18899 · Cited by 750
Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3–independent β-catenin degradation
Topol, L., Jiang, X., Choi, H., Garrett-Beal, L., Carolan, P. J., & Yang, Y. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200303158 · Cited by 724
the Genetic Factors for Osteoporosis (GEFOS) Consortium (2009) · Nature Genetics · doi:10.1038/ng.446 · Cited by 706
Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease
Balemans, W., Patel, N., Ebeling, M., Van Hul, E., Wuyts, W., Lacza, C., Dioszegi, M., Dikkers, F. G., Hildering, P., Willems, P. J., et al. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.2.91 · Cited by 698
Mechanisms of Anabolic Therapies for Osteoporosis
Canalis, E., Giustina, A., & Bilezikian, J. P. (2007) · New England Journal of Medicine · doi:10.1056/nejmra067395 · Cited by 668
Self-citationBianco, P., & Gehron Robey, P. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10413 · Cited by 587
Essential role of β-catenin in postnatal bone acquisition.
Holmen, S. L., Zylstra, C. R., Mukherjee, A., Sigler, R. E., Faugere, M.-C., Bouxsein, M. L., Deng, L., Clemens, T. L., & Williams, B. O. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501900200 · Cited by 584
Van Wesenbeeck, L., Cleiren, E., Gram, J., Beals, R. K., Bénichou, O., Scopelliti, D., Key, L., Renton, T., Bartels, C., Gong, Y., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/368277 · Cited by 568
Osteocyte Wnt/β-Catenin Signaling Is Required for Normal Bone Homeostasis
Kramer, I., Halleux, C., Keller, H., Pegurri, M., Gooi, J. H., Weber, P. B., Feng, J. Q., Bonewald, L. F., & Kneissel, M. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01428-09 · Cited by 567
Maeda, K., Kobayashi, Y., Udagawa, N., Uehara, S., Ishihara, A., Mizoguchi, T., Kikuchi, Y., Takada, I., Kato, S., Kani, S., et al. (2012) · Nature Medicine · doi:10.1038/nm.2653 · Cited by 542
Deletion of a Single Allele of the Dkk1 Gene Leads to an Increase in Bone Formation and Bone Mass
Morvan, F., Boulukos, K., Clément-Lacroix, P., Roman, S. R., Suc-Royer, I., Vayssière, B., Ammann, P., Martin, P., Pinho, S., Pognonec, P., et al. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060311 · Cited by 524
Wnt/β-Catenin Signaling Is a Normal Physiological Response to Mechanical Loading in Bone
Robinson, J. A., Chatterjee-Kishore, M., Yaworsky, P. J., Cullen, D. M., Zhao, W., Li, C., Kharode, Y., Sauter, L., Babij, P., Brown, E. L., et al. (2006) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)84086-3 · Cited by 521
High Bone Mass in Mice Expressing a Mutant LRP5 Gene
Babij, P., Zhao, W., Small, C., Kharode, Y., Yaworsky, P. J., Bouxsein, M. L., Reddy, P. S., Bodine, P. V., Robinson, J. A., Bhat, B., et al. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.6.960 · Cited by 497
Tu, X., Rhee, Y., Condon, K. W., Bivi, N., Allen, M. R., Dwyer, D., Stolina, M., Turner, C. H., Robling, A. G., Plotkin, L. I., et al. (2012) · Bone · doi:10.1016/j.bone.2011.10.025 · Cited by 459
Bodine, P. V. N., Zhao, W., Kharode, Y. P., Bex, F. J., Lambert, A.-J., Goad, M. B., Gaur, T., Stein, G. S., Lian, J. B., & Komm, B. S. (2004) · Molecular Endocrinology · doi:10.1210/me.2003-0498 · Cited by 449
Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease
Loots, G. G., Kneissel, M., Keller, H., Baptist, M., Chang, J., Collette, N. M., Ovcharenko, D., Plajzer-Frick, I., & Rubin, E. M. (2005) · Genome Research · doi:10.1101/gr.3437105 · Cited by 442
Mechanical signals as anabolic agents in bone
Ozcivici, E., Luu, Y. K., Adler, B., Qin, Y.-X., Rubin, J., Judex, S., & Rubin, C. T. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.239 · Cited by 441
Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia
Li, J., Sarosi, I., Cattley, R. C., Pretorius, J., Asuncion, F., Grisanti, M., Morony, S., Adamu, S., Geng, Z., Qiu, W., et al. (2006) · Bone · doi:10.1016/j.bone.2006.03.017 · Cited by 441
Ominsky, M. S., Vlasseros, F., Jolette, J., Smith, S. Y., Stouch, B., Doellgast, G., Gong, J., Gao, Y., Cao, J., Graham, K., et al. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.14 · Cited by 414
Function of osteocytes in bone
Aarden, E. M., Nijweide, P. J., & Burger, E. H. (1994) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240550304 · Cited by 409
The role of Dickkopf-1 in bone development, homeostasis, and disease
Pinzone, J. J., Hall, B. M., Thudi, N. K., Vonau, M., Qiang, Y.-W., Rosol, T. J., & Shaughnessy, J. D. (2009) · Blood · doi:10.1182/blood-2008-03-145169 · Cited by 408
Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma
Fulciniti, M., Tassone, P., Hideshima, T., Vallet, S., Nanjappa, P., Ettenberg, S. A., Shen, Z., Patel, N., Tai, Y.-T., Chauhan, D., et al. (2009) · Blood · doi:10.1182/blood-2008-11-191577 · Cited by 399
Sawakami, K., Robling, A. G., Ai, M., Pitner, N. D., Liu, D., Warden, S. J., Li, J., Maye, P., Rowe, D. W., Duncan, R. L., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601000200 · Cited by 397
Turner, C. H., & Pavalko, F. M. (1998) · Journal of Orthopaedic Science · doi:10.1007/s007760050064 · Cited by 395
Update on Wnt signaling in bone cell biology and bone disease
Monroe, D. G., McGee-Lawrence, M. E., Oursler, M. J., & Westendorf, J. J. (2012) · Gene · doi:10.1016/j.gene.2011.10.044 · Cited by 392
WNT1 Mutations in Early-Onset Osteoporosis and Osteogenesis Imperfecta
Laine, C. M., Joeng, K. S., Campeau, P. M., Kiviranta, R., Tarkkonen, K., Grover, M., Lu, J. T., Pekkinen, M., Wessman, M., Heino, T. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215458 · Cited by 365
Head induction by simultaneous repression of Bmp and Wnt signalling in Xenopus
Glinka, A., Wu, W., Onichtchouk, D., Blumenstock, C., & Niehrs, C. (1997) · Nature · doi:10.1038/39092 · Cited by 350
Ellies, D. L., Viviano, B., McCarthy, J., Rey, J.-P., Itasaki, N., Saunders, S., & Krumlauf, R. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060810 · Cited by 350
Decreased BMD and Limb Deformities in Mice Carrying Mutations in Both Lrp5 and Lrp6
Holmen, S. L., Giambernardi, T. A., Zylstra, C. R., Buckner-Berghuis, B. D., Resau, J. H., Hess, J. F., Glatt, V., Bouxsein, M. L., Ai, M., Warman, M. L., et al. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040907 · Cited by 344
Wise, a context-dependent activator and inhibitor of Wnt signalling
Itasaki, N., Jones, C. M., Mercurio, S., Rowe, A., Domingos, P. M., Smith, J. C., & Krumlauf, R. (2003) · Development · doi:10.1242/dev.00674 · Cited by 321
Mirza, F. S., Padhi, I. D., Raisz, L. G., & Lorenzo, J. A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2283 · Cited by 311
Noncanonical Wnt Signaling through G Protein-Linked PKCδ Activation Promotes Bone Formation
Tu, X., Joeng, K. S., Nakayama, K. I., Nakayama, K., Rajagopal, J., Carroll, T. J., McMahon, A. P., & Long, F. (2007) · Developmental Cell · doi:10.1016/j.devcel.2006.11.003 · Cited by 311
Staehling‐Hampton, K., Proll, S., Paeper, B. W., Zhao, L., Charmley, P., Brown, A., Gardner, J. C., Galas, D., Schatzman, R. C., Beighton, P., et al. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10401 · Cited by 294
Mutations in WNT1 Cause Different Forms of Bone Fragility
Keupp, K., Beleggia, F., Kayserili, H., Barnes, A. M., Steiner, M., Semler, O., Fischer, B., Yigit, G., Janda, C. Y., Becker, J., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.02.010 · Cited by 289
Osteocyte RANKL: New insights into the control of bone remodeling
Xiong, J., & O'Brien, C. A. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1547 · Cited by 287
The mechanism of coupling: a role for the vasculature
Parfitt, A. M. (2000) · Bone · doi:10.1016/s8756-3282(00)80937-0 · Cited by 283
Wnt10b Increases Postnatal Bone Formation by Enhancing Osteoblast Differentiation
Bennett, C. N., Ouyang, H., Ma, Y. L., Zeng, Q., Gerin, I., Sousa, K. M., Lane, T. F., Krishnan, V., Hankenson, K. D., & MacDougald, O. A. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.070810 · Cited by 281
Playford, M. P., Bicknell, D., Bodmer, W. F., & Macaulay, V. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.210394297 · Cited by 280
Kansara, M., Tsang, M., Kodjabachian, L., Sims, N. A., Trivett, M. K., Ehrich, M., Dobrovic, A., Slavin, J., Choong, P. F. M., Simmons, P. J., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37175 · Cited by 272
Laurikkala, J., Kassai, Y., Pakkasjärvi, L., Thesleff, I., & Itoh, N. (2003) · Developmental Biology · doi:10.1016/j.ydbio.2003.08.011 · Cited by 270
Heath, D. J., Chantry, A. D., Buckle, C. H., Coulton, L., Shaughnessy, J. D., Evans, H. R., Snowden, J. A., Stover, D. R., Vanderkerken, K., & Croucher, P. I. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.081104 · Cited by 243
Deregowski, V., Gazzerro, E., Priest, L., Rydziel, S., & Canalis, E. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m508370200 · Cited by 231
Self-citationLRP5 Mutations Linked to High Bone Mass Diseases Cause Reduced LRP5 Binding and Inhibition by SOST
Semenov, M. V., & He, X. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m609509200 · Cited by 222
Choi, H. Y., Dieckmann, M., Herz, J., & Niemeier, A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007930 · Cited by 208
Pyott, S. M., Tran, T. T., Leistritz, D. F., Pepin, M. G., Mendelsohn, N. J., Temme, R. T., Fernandez, B. A., Elsayed, S. M., Elsobky, E., Verma, I., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.02.009 · Cited by 208
Where Wnts Went: The Exploding Field of Lrp5 and Lrp6 Signaling in Bone
Williams, B. O., & Insogna, K. L. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.081235 · Cited by 207
Clarke, B. L. (2009) · Yearbook of Endocrinology · doi:10.1016/s0084-3741(09)79307-2 · Cited by 200
Mutations in WNT1 are a cause of osteogenesis imperfecta
Fahiminiya, S., Majewski, J., Mort, J., Moffatt, P., Glorieux, F. H., & Rauch, F. (2013) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2013-101567 · Cited by 198
Effects of PTH on osteocyte function
Bellido, T., Saini, V., & Pajevic, P. D. (2013) · Bone · doi:10.1016/j.bone.2012.09.016 · Cited by 196
Determinants of serum sclerostin in healthy pre- and postmenopausal women
Ardawi, M.-S. M., Al-Kadi, H. A., Rouzi, A. A., & Qari, M. H. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.479 · Cited by 193
Biphasic and Dosage-Dependent Regulation of Osteoclastogenesis by β-Catenin
Wei, W., Zeve, D., Suh, J. M., Wang, X., Du, Y., Zerwekh, J. E., Dechow, P. C., Graff, J. M., & Wan, Y. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05980-11 · Cited by 181
Bone Mineral Density in Sclerosteosis; Affected Individuals and Gene Carriers
Gardner, J. C., van Bezooijen, R. L., Mervis, B., Hamdy, N. A. T., Löwik, C. W. G. M., Hamersma, H., Beighton, P., & Papapoulos, S. E. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1235 · Cited by 178
Wnt signaling and skeletal development
Liu, F., Kohlmeier, S. E., & Wang, C.-Y. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.11.011 · Cited by 176
Wang, F.-S., Ko, J.-Y., Yeh, D.-W., Ke, H.-C., & Wu, H.-L. (2008) · Endocrinology · doi:10.1210/en.2007-0910 · Cited by 173
Haydon, R. C., Deyrup, A., Ishikawa, A., Heck, R., Jiang, W., Zhou, L., Feng, T., King, D., Cheng, H., Breyer, B., et al. (2002) · International Journal of Cancer · doi:10.1002/ijc.10719 · Cited by 171
TREM2 and β-Catenin Regulate Bone Homeostasis by Controlling the Rate of Osteoclastogenesis
Otero, K., Shinohara, M., Zhao, H., Cella, M., Gilfillan, S., Colucci, A., Faccio, R., Ross, F. P., Teitelbaum, S. L., Takayanagi, H., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102836 · Cited by 171
Li, Y., Pawlik, B., Elcioglu, N., Aglan, M., Kayserili, H., Yigit, G., Percin, F., Goodman, F., Nürnberg, G., Cenani, A., et al. (2010) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.03.004 · Cited by 171
The Bone Remodeling Compartment: A Circulatory Function for Bone Lining Cells
Parfitt, A. M. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.9.1583 · Cited by 169
Edwards, C. M., Edwards, J. R., Lwin, S. T., Esparza, J., Oyajobi, B. O., McCluskey, B., Munoz, S., Grubbs, B., & Mundy, G. R. (2008) · Blood · doi:10.1182/blood-2007-03-077685 · Cited by 160
Van Buchem Disease (Hyperostosis Corticalis Generalisata) Maps to Chromosome 17q12-q21
Van Hul, W., Balemans, W., Van Hul, E., Dikkers, F. G., Obee, H., Stokroos, R. J., Hildering, P., Vanhoenacker, F., Van Camp, G., & Willems, P. J. (1998) · The American Journal of Human Genetics · doi:10.1086/301721 · Cited by 158
Piters, E., Boudin, E., & Hul, W. V. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.03.006 · Cited by 149
β-catenin promotes bone formation and suppresses bone resorption in postnatal growing mice
Chen, J., & Long, F. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1834 · Cited by 145
Bradley, E. W., & Drissi, H. (2010) · Molecular Endocrinology · doi:10.1210/me.2010-0037 · Cited by 140
Targeted deletion of Sost distal enhancer increases bone formation and bone mass
Collette, N. M., Genetos, D. C., Economides, A. N., Xie, L., Shahnazari, M., Yao, W., Lane, N. E., Harland, R. M., & Loots, G. G. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1207188109 · Cited by 140
Bodine, P. V. N., Stauffer, B., Ponce‐de‐Leon, H., Bhat, R. A., Mangine, A., Seestaller‐Wehr, L., Moran, R. A., Billiard, J., Fukayama, S., Komm, B. S., et al. (2009) · Bone · doi:10.1016/j.bone.2009.02.013 · Cited by 131
Osteoblast-Targeted Expression of Sfrp4 in Mice Results in Low Bone Mass
Nakanishi, R., Akiyama, H., Kimura, H. J., Otsuki, B., Shimizu, M., Tsuboyama, T., & Nakamura, T. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.071007 · Cited by 129
Wang, F., Lin, C., Chen, Y.-J., Wang, C., Yang, K. D., Huang, Y., Sun, Y., & Huang, H.-C. (2005) · Endocrinology · doi:10.1210/en.2004-1050 · Cited by 126
Growth factor control of bone mass
CANALIS, E. M. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22322 · Cited by 123
Self-citationSurmann‐Schmitt, C., Widmann, N., Dietz, U. H., Saeger, B., Eitzinger, N., Nakamura, Y., Rattel, M., Latham, R., Hartmann, C., von der Mark, H., et al. (2009) · Journal of Cell Science · doi:10.1242/jcs.048926 · Cited by 119
Recessively Inherited Forms of Osteogenesis Imperfecta
Byers, P. H., & Pyott, S. M. (2012) · Annual Review of Genetics · doi:10.1146/annurev-genet-110711-155608 · Cited by 115
The Genetics of Low-Density Lipoprotein Receptor-Related Protein 5 in Bone: A Story of Extremes
Balemans, W., & Hul, W. V. (2007) · Endocrinology · doi:10.1210/en.2006-1352 · Cited by 112
van Lierop, A. H., Witteveen, J. E., Hamdy, N. A. T., & Papapoulos, S. E. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0699 · Cited by 108
Betts, A. M., Clark, T. H., Yang, J., Treadway, J. L., Li, M., Giovanelli, M. A., Abdiche, Y. N., Stone, D. M., & Paralkar, V. M. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.164129 · Cited by 103
Glantschnig, H., Hampton, R. A., Lü, P., Zhao, J. Z., Vitelli, S., Huang, L., Haytko, P., Cusick, T. E., Ireland, C., Jarantow, S. W., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.166892 · Cited by 100
Microarray analysis reveals expression regulation of Wnt antagonists in differentiating osteoblasts
Vaes, B., Dechering, K. J., VANSOMEREN, E., HENDRIKS, J., VANDEVEN, C., Feijen, A., Mummery, C. L., Reinders, M. J. T., Olijve, W., VANZOELEN, E., et al. (2005) · Bone · doi:10.1016/j.bone.2005.02.001 · Cited by 100
RANKL subcellular trafficking and regulatory mechanisms in osteocytes
Honma, M., Ikebuchi, Y., Kariya, Y., Hayashi, M., Hayashi, N., Aoki, S., & Suzuki, H. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1941 · Cited by 98
Update in new anabolic therapies for osteoporosis
Canalis, E. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2677 · Cited by 85
Self-citationDisruption of LRP6 in osteoblasts blunts the bone anabolic activity of PTH
Li, C., Xing, Q., Yu, B., Xie, H., Wang, W., Shi, C., Crane, J. L., Cao, X., & Wan, M. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1962 · Cited by 81
In vivo and in vitro effects of a novel anti-Dkk1 neutralizing antibody in multiple myeloma
Pozzi, S., Fulciniti, M., Yan, H., Vallet, S., Eda, H., Patel, K. J., Santo, L., Cirstea, D. D., Hideshima, T., Schirtzinge, L., et al. (2013) · Bone · doi:10.1016/j.bone.2013.01.012 · Cited by 76
The Fate of Circulating Osteoblasts
CANALIS, E. M. (2005) · New England Journal of Medicine · doi:10.1056/nejme058080 · Cited by 74
Self-citationFirst missense mutation in the SOST gene causing sclerosteosis by loss of sclerostin function
Piters, E., Çulha, C., Moester, M. J. C., Bezooijen, R. V., Adriaensen, D., Mueller, T. D., Weidauer, S. E., Jennes, K., de Freitas, F., Löwik, C., et al. (2010) · Human Mutation · doi:10.1002/humu.21274 · Cited by 68
Bisphosphonates in the Treatment of Osteoporosis
Diab, D. L., & Watts, N. B. (2012) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2012.04.007 · Cited by 62
Jastrzebski, S. L., Kalinowski, J., Stolina, M., Mirza, F., Torreggiani, E., Kalajzić, I., Won, H. Y., Lee, S., & Lorenzo, J. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1773 · Cited by 53
Bhat, B. M., Allen, K. M., Liu, W. X., Graham, J. F., Morales, A., Anisowicz, A., Lam, H., McCauley, C., Coleburn, V. E., Cain, M., et al. (2006) · Gene · doi:10.1016/j.gene.2006.12.014 · Cited by 48
Serum sclerostin levels in men with idiopathic osteoporosis
Lapauw, B., Vandewalle, S., Taes, Y., Goemaere, S., Zmierczak, H., Collette, J., & Kaufman, J. (2013) · European Journal of Endocrinology · doi:10.1530/eje-12-1074 · Cited by 32
Novel SOST gene mutation in a sclerosteosis patient and her parents
Bhadada, S. K., Rastogi, A., Steenackers, E., Boudin, E., Arya, A. K., Dhiman, V., Bhansali, A., & Hul, W. V. (2012) · Bone · doi:10.1016/j.bone.2012.10.009 · Cited by 25
Skeletal actions of insulin-like growth factors
Gazzerro, E., & CANALIS, E. M. (2006) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.1.1.47 · Cited by 24
Self-citationZanotti, S., & CANALIS, E. M. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23365 · Cited by 22
Self-citationFuture Directions in Osteoporosis Therapeutics
Bone, H. G. (2012) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2012.05.003 · Cited by 20
Cited by
Osteoblast Differentiation and Bone Matrix Formation In Vivo and In Vitro
Blair, H. C., Larrouture, Q. C., Li, Y., Lin, H., Beer-Stoltz, D., Liu, L., Tuan, R. S., Robinson, L. J., Schlesinger, P. H., & Nelson, D. J. (2017) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2016.0454 · Cited by 484
The role of the wnt/β-catenin signaling pathway in formation and maintenance of bone and teeth
Duan, P., & Bonewald, L. F. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.05.015 · Cited by 375
MANAGEMENT OF ENDOCRINE DISEASE: Secondary osteoporosis: pathophysiology and management
Mirza, F., & Canalis, E. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0118 · Cited by 331
Self-citationNotch Signaling and the Skeleton
Zanotti, S., & Canalis, E. (2016) · Endocrine Reviews · doi:10.1210/er.2016-1002 · Cited by 321
Self-citationOsteoporosis: Mechanism, Molecular Target and Current Status on Drug Development
Li, H., Xiao, Z., Quarles, L. D., & Li, W. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867327666200330142432 · Cited by 226
Metadata
- Authors
- Canalis, E.
- Venue
- Nature Reviews Endocrinology
- Published
- 2013-08-13
- Volume
- 9
- Issue
- 10
- Pages
- 575-583
- ISSN
- 1759-5029 (ISSN-L)
- 1759-5037
- OpenAlex
- W2045936444
- Cited by
- 304
- References
- 130
- FWCI
- 5.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.